HER2 positive breast cancer

被引：0
|
作者：
Gianni, Luca
Bianchini, Giampaolo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-ED11-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ED11-2
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Locoregional recurrence in patients with HER2 positive breast cancer
    Brollo, Janaina
    Kneubil, Maximiliano Cassilha
    Botteri, Edoardo
    Rotmensz, Nicole
    Duso, Bruno Achutti
    Fumagalli, Luca
    Locatelli, Marzia Adelia
    Criscitiello, Carmen
    Lohsiriwat, Visnu
    Goldhirsch, Aron
    Leonardi, Maria Cristina
    Orecchia, Roberto
    Curigliano, Giuseppe
    BREAST, 2013, 22 (05): : 856 - 862
  • [22] What therapies are on the horizon for HER2 positive breast cancer?
    Viale, Giulia
    Morganti, Stefania
    Ferraro, Emanuela
    Zagami, Paola
    Marra, Antonio
    Curigliano, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (09) : 811 - 822
  • [23] THE UPFRONT THERAPY FOR HER2 POSITIVE BREAST CANCER PATIENTS
    Iwata, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [24] Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    Wahler J.
    Suh N.
    Current Pharmacology Reports, 2015, 1 (5) : 324 - 335
  • [25] Immune Effects of Transtuzumab in HER2 Positive Breast Cancer
    Zgura, Anca
    Gales, Laurentia
    Haineala, Bogdan
    Bratila, Elvira
    Mehedintu, Claudia
    Barac, Ramona Ileana
    Berceanu, Costin
    Andreescu, Cristina Veronica
    Brinduse, Lacramioara Aurelia
    Ionescu, Alec
    Anghel, Rodica
    REVISTA DE CHIMIE, 2019, 70 (08): : 2791 - 2794
  • [26] Novel therapies for metastatic HER2 positive breast cancer
    Cossetti R.J.D.
    Gelmon K.A.
    Current Breast Cancer Reports, 2013, 5 (4) : 331 - 340
  • [27] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
  • [28] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [29] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [30] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
    Wei, T.
    Wang, D.
    Peng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
12345